Sign up to save your podcasts
Or
Share BioRN Reports Surge in US Applications as Scientists Seek New Opportunities - Interview with Dr. Julia Schaft, Managing Director
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BioRN Reports Surge in US Applications as Scientists Seek New Opportunities - Interview with Dr. Julia Schaft, Managing Director
"We are seeing a doubling or tripling of applications from the United States. You can really feel that shift already. People have been offered jobs and professorships and are already here in Heidelberg."
Dr. Julia Schaft, Managing Director at BioRN Cluster Management GmbH, reveals the significant increase in American scientists exploring opportunities in Germany's Rhine-Neckar biotech hub as researchers seek new environments that support their work.
Julia brings over a decade of international experience, including 11 years in Australia working with human embryonic stem cells, before returning to Germany to drive innovation at the intersection of industry and academia. She also serves as spokesperson for bioDeutschland's Working Group of BioRegions.
In the latest PharmaSource podcast episode, Julia explains how changing dynamics are creating new opportunities for European life science clusters and what this means for the global biotech landscape.
https://pharmasource.global/content/podcast/the-heidelberg-advantage-biorn/
View all episodes
By Life Science Networks"We are seeing a doubling or tripling of applications from the United States. You can really feel that shift already. People have been offered jobs and professorships and are already here in Heidelberg."
Dr. Julia Schaft, Managing Director at BioRN Cluster Management GmbH, reveals the significant increase in American scientists exploring opportunities in Germany's Rhine-Neckar biotech hub as researchers seek new environments that support their work.
Julia brings over a decade of international experience, including 11 years in Australia working with human embryonic stem cells, before returning to Germany to drive innovation at the intersection of industry and academia. She also serves as spokesperson for bioDeutschland's Working Group of BioRegions.
In the latest PharmaSource podcast episode, Julia explains how changing dynamics are creating new opportunities for European life science clusters and what this means for the global biotech landscape.
https://pharmasource.global/content/podcast/the-heidelberg-advantage-biorn/